Brian Sgard1,2, Maya Khalifé3, Arthur Bouchut3, Brice Fernandez4, Marine Soret5,6, Alain Giron6, Clara Zaslavsky7, Gaspar Delso8, Marie-Odile Habert5,6, Aurélie Kas5,6. 1. Department of Nuclear Medicine, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, 75013, APHP, Paris, France. sgardbrian@gmail.com. 2. Laboratoire d'Imagerie Biomédicale (LIB), Sorbonne Université, CNRS, INSERM, 75006, Paris, France. sgardbrian@gmail.com. 3. Centre de NeuroImagerie de Recherche (CENIR), Institut du Cerveau et de la Moelle épinière (ICM), Paris, France. 4. Applications and Workflow, GE Healthcare, Orsay, France. 5. Department of Nuclear Medicine, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, 75013, APHP, Paris, France. 6. Laboratoire d'Imagerie Biomédicale (LIB), Sorbonne Université, CNRS, INSERM, 75006, Paris, France. 7. Department of Biophysics, Sorbonne Université, 75013, Paris, France. 8. Applications and Workflow, GE Healthcare, Cambridge, UK.
Abstract
OBJECTIVE: One of the main challenges of integrated PET/MR is to achieve an accurate PET attenuation correction (AC), especially in brain acquisition. Here, we evaluated an AC method based on zero echo time (ZTE) MRI, comparing it with the single-atlas AC method and CT-based AC, set as reference. METHODS: Fifty patients (70 ± 11 years old, 28 men) underwent FDG-PET/MR examination (SIGNA PET/MR 3.0 T, GE Healthcare) as part of the investigation of suspected dementia. They all had brain computed tomography (CT), 2-point LAVA-flex MRI (for atlas-based AC), and ZTE-MRI. Two AC methods were compared with CT-based AC (CTAC): one based on a single atlas, one based on ZTE segmentation. Impact on brain metabolism was evaluated using voxel and volumes of interest-based analyses. The impact of AC was also evaluated through comparisons between two subgroups of patients extracted from the whole population: 15 patients with mild cognitive impairment and normal metabolic pattern, and 22 others with metabolic pattern suggestive of Alzheimer disease, using SPM12 software. RESULTS: ZTE-AC yielded a lower bias (3.6 ± 3.2%) than the atlas method (4.5 ± 6.1%) and lowest interindividual (4.6% versus 6.8%) and inter-regional (1.4% versus 2.6%) variabilities. Atlas-AC resulted in metabolism overestimation in cortical regions near the vertex and cerebellum underestimation. ZTE-AC yielded a moderate metabolic underestimation mainly in the occipital cortex and cerebellum. Voxel-wise comparison between the two subgroups of patients showed that significant difference clusters had a slightly smaller size but similar locations with PET images corrected with ZTE-AC compared with those corrected with CT, whereas atlas-AC images showed a notable reduction of significant voxels. CONCLUSION: ZTE-AC performed better than atlas-AC in detecting pathologic areas in suspected neurodegenerative dementia. KEY POINTS: • The ZTE-based AC improved the accuracy of the metabolism quantification in PET compared with the atlas-AC method. • The overall uptake bias was 21% lower when using ZTE-based AC compared with the atlas-AC method. • ZTE-AC performed better than atlas-AC in detecting pathologic areas in suspected neurodegenerative dementia.
OBJECTIVE: One of the main challenges of integrated PET/MR is to achieve an accurate PET attenuation correction (AC), especially in brain acquisition. Here, we evaluated an AC method based on zero echo time (ZTE) MRI, comparing it with the single-atlas AC method and CT-based AC, set as reference. METHODS: Fifty patients (70 ± 11 years old, 28 men) underwent FDG-PET/MR examination (SIGNA PET/MR 3.0 T, GE Healthcare) as part of the investigation of suspected dementia. They all had brain computed tomography (CT), 2-point LAVA-flex MRI (for atlas-based AC), and ZTE-MRI. Two AC methods were compared with CT-based AC (CTAC): one based on a single atlas, one based on ZTE segmentation. Impact on brain metabolism was evaluated using voxel and volumes of interest-based analyses. The impact of AC was also evaluated through comparisons between two subgroups of patients extracted from the whole population: 15 patients with mild cognitive impairment and normal metabolic pattern, and 22 others with metabolic pattern suggestive of Alzheimer disease, using SPM12 software. RESULTS: ZTE-AC yielded a lower bias (3.6 ± 3.2%) than the atlas method (4.5 ± 6.1%) and lowest interindividual (4.6% versus 6.8%) and inter-regional (1.4% versus 2.6%) variabilities. Atlas-AC resulted in metabolism overestimation in cortical regions near the vertex and cerebellum underestimation. ZTE-AC yielded a moderate metabolic underestimation mainly in the occipital cortex and cerebellum. Voxel-wise comparison between the two subgroups of patients showed that significant difference clusters had a slightly smaller size but similar locations with PET images corrected with ZTE-AC compared with those corrected with CT, whereas atlas-AC images showed a notable reduction of significant voxels. CONCLUSION: ZTE-AC performed better than atlas-AC in detecting pathologic areas in suspected neurodegenerative dementia. KEY POINTS: • The ZTE-based AC improved the accuracy of the metabolism quantification in PET compared with the atlas-AC method. • The overall uptake bias was 21% lower when using ZTE-based AC compared with the atlas-AC method. • ZTE-AC performed better than atlas-AC in detecting pathologic areas in suspected neurodegenerative dementia.
Authors: N Tzourio-Mazoyer; B Landeau; D Papathanassiou; F Crivello; O Etard; N Delcroix; B Mazoyer; M Joliot Journal: Neuroimage Date: 2002-01 Impact factor: 6.556
Authors: Andrew P Leynes; Jaewon Yang; Florian Wiesinger; Sandeep S Kaushik; Dattesh D Shanbhag; Youngho Seo; Thomas A Hope; Peder E Z Larson Journal: J Nucl Med Date: 2017-10-30 Impact factor: 10.057
Authors: Ahmadreza Rezaei; Georg Schramm; Stefanie M A Willekens; Gaspar Delso; Koen Van Laere; Johan Nuyts Journal: J Nucl Med Date: 2019-04-12 Impact factor: 10.057
Authors: Claes N Ladefoged; Ian Law; Udunna Anazodo; Keith St Lawrence; David Izquierdo-Garcia; Ciprian Catana; Ninon Burgos; M Jorge Cardoso; Sebastien Ourselin; Brian Hutton; Inés Mérida; Nicolas Costes; Alexander Hammers; Didier Benoit; Søren Holm; Meher Juttukonda; Hongyu An; Jorge Cabello; Mathias Lukas; Stephan Nekolla; Sibylle Ziegler; Matthias Fenchel; Bjoern Jakoby; Michael E Casey; Tammie Benzinger; Liselotte Højgaard; Adam E Hansen; Flemming L Andersen Journal: Neuroimage Date: 2016-12-14 Impact factor: 6.556
Authors: Tetsuro Sekine; Alfred Buck; Gaspar Delso; Bradley Kemp; Edwin E G W Ter Voert; Martin Huellner; Patrick Veit-Haibach; Sandeep Kaushik; Florian Wiesinger; Geoffrey Warnock Journal: PLoS One Date: 2020-06-03 Impact factor: 3.240
Authors: Francesca De Luca; Martin Bolin; Lennart Blomqvist; Cecilia Wassberg; Heather Martin; Anna Falk Delgado Journal: BMC Med Imaging Date: 2020-11-25 Impact factor: 1.930
Authors: João M Sousa; Lieuwe Appel; Inés Merida; Rolf A Heckemann; Nicolas Costes; Mathias Engström; Stergios Papadimitriou; Dag Nyholm; Håkan Ahlström; Alexander Hammers; Mark Lubberink Journal: EJNMMI Phys Date: 2020-12-28